DE102013203227A1 - Multitonal one-step dyeings IV - Google Patents

Abstract

Process for the oxidative dyeing of keratin fibers, in which a cosmetic agent (A) is applied to the fibers and left to act for a period of 30 seconds to 30 minutes, then a cosmetic agent (B) on the keratin fibers, which is still with the Agents (A) are applied and both agents (A) and (B) are allowed to act for a period of 5 to 45 minutes, after which agents (A) and (B) are rinsed out, allowing lively and natural multitoneal colorations with " highlights "or" lowlights ", if the agent (A) (a1) does not contain any oxidation dye precursors, (a2) has a pH value of 8.0 to 14.0, and the agent (B) (b1) has one or more oxidation dye precursors contains, (b2) contains one or more oxidizing agents and (b3) has a pH of 8.0 to 12.0.

Description

The subject matter of the present application is a method for the treatment of keratinous fibers, which makes it possible to color the hair in a staining step and at the same time to produce a multitonale staining with brighter ("highlights") or darker ("lowlights") parts (streaks).

Over time, and in particular under the influence of external influences such as light or atmospheric pollutants, the hair loses or changes its natural color and its shine. For this reason, hair dyes are widely used, which are used either in the hairdressing area or by the home application. For permanent, intensive colorations with corresponding fastness properties, so-called oxidation colorants are used. Such colorants usually contain oxidation dye precursors, so-called developer components and coupler components, which under the influence of oxidizing agents or of atmospheric oxygen form the actual dyes with one another. The oxidation stains are characterized by excellent, long lasting staining results. For temporary dyeings usually dyeing or tinting agents are used, which contain as coloring component so-called substantive dyes ("direct drawers"). In addition to coloring, brightening one's own hair color or bleaching is the very special wish of many consumers, as a blonde hair color is considered attractive and fashionable in terms of desirable. If substrates are to be lightened or even bleached, the dyes coloring the substrate are usually decolorized oxidatively using appropriate oxidizing agents, such as hydrogen peroxide.

When coloring hair - especially in home-use hair dyeing - the problem arises that natural color nuances are completely masked, making it difficult to produce multitonal dyeings.

In order to give the hair a more natural appearance, it is proposed to discolor dyed hair partially by targeted application of oxidizing agents. The hair parts ("highlights"), on which the oxidizing agents are applied, bleach at least partially, resulting in a multitonale hair color. The application of the oxidizing agent is carried out with a brush or a brush, the hair to be treated, if necessary, with aluminum foil or a so-called "highlight cap" are protected from discoloration.

Although this type of application solves the problem of the most natural possible coloring of hair, but allows only the setting of "highlights". For lowlights, i. darker parts would have to be colored. In each case, a time-consuming second decolorization or dyeing step is needed, following the original staining. For home use in particular, the entire hair must first be chlorinated before the user can set "highlights" or "lowlights". This is perceived by many consumers to be too time-consuming and frustrating because the essential color-changing step initially occurs and is "corrected" in a second step.

It is an object of the present invention to provide a method which allows for multitonal staining in a single staining step. In this case, the coloring of the hair should be accompanied by the production of "highlights" or "lowlights", so that after rinsing the dye directly a result is visible.

It has now been found that a partial pretreatment of fiber areas or highlights leads to the fact that these areas or highlights are colored later more intensively or less intensively. Through the pre-penetration of individual fiber areas or highlights, the colorant applied immediately thereafter colors the hair multitonally, and the consumer can admire a natural dyeing result with "highlights" or "lowlights" directly after the dyeing step.

• A) Applikation eines kosmetischen Mittels (A) auf die Fasern,
• B) Einwirkenlassen des Mittels (A) für einen Zeitraum von 30 Sekunden bis 30 Minuten,
• C) Applikation eines kosmetischen Mittels (B) auf die keratinischen Fasern, die noch mit dem Mittel (A) beaufschlagt sind,
• D) Einwirkenlassen beider Mittel (A) und (B) für einen Zeitraum von 5 bis 45 Minuten,
• E) Ausspülen der Mittel (A) und (B),

dadurch gekennzeichnet, dass

• – das Mittel (A) (a1) keine Oxidationsfarbstoffvorprodukte enthält, (a2) einen pH-Wert von 8,0 bis 14,0 besitzt,
• – das Mittel (B) (b1) ein oder mehrere Oxidationsfarbstoffvorprodukte enthält, (b2) eine oder mehrere Oxidationsmittel enthält und (b3) einen pH-Wert von 8,0 bis 12,0 besitzt.

In a first embodiment, the present invention relates to a process for the oxidative dyeing of keratinic fibers, comprising the steps

• A) application of a cosmetic agent (A) to the fibers,
• B) exposing the agent (A) to a period of 30 seconds to 30 minutes,
• C) applying a cosmetic agent (B) to the keratinic fibers which are still exposed to the agent (A),
• D) exposing both agents (A) and (B) for a period of 5 to 45 minutes,
• E) rinsing out the means (A) and (B),

characterized in that

• - the agent (A) (a1) contains no oxidation dye precursors, (a2) has a pH of 8.0 to 14.0,
• - the agent (B) (b1) contains one or more oxidation dye precursors, (b2) contains one or more oxidizing agents and (b3) has a pH of 8.0 to 12.0.

In the first step of the method according to the invention, a cosmetic agent (A) is applied to the fibers. This agent (A), which is also referred to below as a pretreatment agent or as a pre-penetration agent, is left on the keratinic fibers for a period of 30 seconds to 30 minutes (step B) of the method according to the invention). Preferred processes according to the invention are characterized by rather shorter reaction times of the pretreatment agent. Particularly preferred methods according to the invention are characterized in that the agent (A) in step B) is allowed to act on the fibers for a period of from 30 seconds to 15 minutes, preferably from 30 seconds to 10 minutes and more preferably from 30 seconds to 5 minutes ,

In order to produce multitonal stains, the agent (A) should not be uniformly applied to the keratinic fibers. Preferably, only individual areas, more preferably only individual strands, are acted upon by the agent (A). Alternatively, the concentration of agent A on individual highlights can be varied. It is also possible first to apply uniformly the entire keratinic fibers to the agent (A) and then to treat individual regions once more with the agent (A). A repeated treatment of individual areas / strands with the agent (A) is possible according to the invention.

Particularly preferred methods according to the invention are characterized in that the application of the cosmetic agent (A) to the fibers in step A) takes place only on individual highlights.

Following the exposure time of the pretreatment agent, the keratinic fibers are not rinsed or tered. Rather, in step C) of the method according to the invention, a cosmetic agent (B) is applied to the fibers still applied with the agent (A). The mixture of the agents (A) and (B) resulting from application of the agent (B) to the keratinic fibers is allowed to act in step D) of the process according to the invention for a period of 5 to 45 minutes.

Preferred processes according to the invention are characterized by rather shorter reaction times of the mixture of the agents (A) and (B). Particularly preferred processes according to the invention are characterized in that the agents (A) and (B) in step D) are allowed to act for a period of from 5 to 30 minutes, preferably from 5 to 20 minutes, particularly preferably from 5 to 15 minutes.

The latter exposure times relate to the mixture of the agents (A) and (B). Since the agent (A) has already acted in step B) of the method according to the invention, the fibers as a whole have longer contact with the ingredients of the agent (A) than with the agent (B). If the agent (A) has been averted only on individual strands or in individual areas, the ingredients of the agent (A) could act more intensively in these areas and thus increase or decrease the effect of the ingredients of the agent (B) in these areas a darker or lighter coloration of these areas is achieved.

After rinsing out the agents (A) and (B) in step E) of the method according to the invention, the consumer immediately experiences a multinal color experience without having to take another step.

According to the invention, the agent (A) has a pH of 8.0 to 14.0 (a2) and is free of oxidation dye precursors, ie of developers and of couplers (a1).

Organic alkalizing agents which can be used according to the invention are preferably selected from alkanolamines of primary, secondary or tertiary amines having a C ₂ -C ₆ -alkyl basic body which carries at least one hydroxyl group. Very particularly preferred alkanolamines according to the invention are selected from the group consisting of 2-aminoethane-1-ol (monoethanolamine), 2-amino-2-methylpropan-1-ol and 2-amino-2-methylpropane-1,3-diol. A particularly preferred alkanolamine is monoethanolamine. Suitable basic amino acids are lysine, arginine and ornithine. The inorganic alkalizing agent according to the invention are preferably selected from the group sodium hydroxide, potassium hydroxide, calcium hydroxide, barium hydroxide, sodium phosphate, potassium phosphate, sodium silicate, potassium silicate, sodium carbonate and potassium carbonate.

Processes which are particularly preferred according to the invention are characterized in that the agent (A) comprises one or more alkalizing agents selected from the group consisting of sodium hydroxide, potassium hydroxide, ammonia, monoethanolamine and 2-amino-2-methyl-1-propanol in a total amount of from 0.3 to 4, 5 wt .-%, preferably 0.5 to 3.5 wt .-%, more preferably from 0.7 to 2.5 wt .-% and particularly preferably from 0.9 to 1.5 wt .-% - related on the total weight of the agent (A) - contains.

Particularly preferred methods according to the invention are characterized in that the agent (A) contains one or more combinations of the following alkalizing agents: sodium hydroxide / potassium hydroxide; Sodium hydroxide / monoethanolamine; Potassium hydroxide / monoethanolamine; Sodium hydroxide / ammonia; Potassium hydroxide / ammonia; Monoethanolamine / 2-amino-2-methyl-1-propanol; Sodium hydroxide / 2-amino-2-methyl-1-propanol and / or potassium hydroxide / 2-amino-2-methyl-1-propanol.

The pretreatment agent (A) has a pH of 8.0 to 14.0 (a2). Preferred processes according to the invention are characterized in that the agent (A) has a pH (a3) of 8.5 to 11.5, preferably of 8.8 to 11.0, more preferably of 9.0 to 10.8 and more preferably from 9.2 to 10.5.

In order to be able to apply the pre-penetration agent (A) cleanly and locally, a higher viscosity of the composition has proved to be advantageous. It is advantageous if the agent is not present as a paste, viscous cream or thickened gel, but has sufficient fluidity. Furthermore, while the ready-to-use agent must have rheological properties that allow it to be applied to the fibers to be dyed, it also prevents bleeding or leakage of the agent from the site of action during its duration of use. Therefore, the agents (A) preferably have a viscosity of 5 to 100 Pa · s, preferably 10 to 50 Pa · s, especially 10 to 20 Pa · s and particularly preferably 10 to 16 Pa · s (Brookfield, 22 ° C, spindle # 5, 4 rpm). For this purpose, preferred agents (A) contain at least one thickener and / or at least one gelling agent. Corresponding processes according to the invention in which the agent (A) additionally contains at least one thickener and / or at least one gelling agent are preferred according to the invention.

In a further embodiment, particularly preferred pre-penetration agents (A) are therefore characterized in that they contain at least one anionic, polymeric thickener. Preferred anionic polymeric thickeners are selected from crosslinked or uncrosslinked copolymers containing at least two different monomers from the group consisting of acrylic acid, methacrylic acid, the C ₁ -C ₆ -alkyl esters of acrylic acid and / or the C ₁ -C ₆ -alkyl esters of methacrylic acid.

Particularly preferred anionic copolymers are copolymers of acrylic acid, methacrylic acid or their C ₁ -C ₆ -alkyl esters, which are marketed under the INCI name Acrylates Copolymer. Particularly preferred is the combination of methacrylic acid and ethyl acrylate and optionally crosslinking, multifunctional monomers. A preferred commercial product for example Aculyn ^® 33 and 33A, which is available from Rohm & Haas.

The anionic polymeric thickening agents may preferably be used in a total amount of from 0.1 to 15% by weight, more preferably from 1 to 10% by weight, and most preferably from 1.5 to 7.5% by weight, with the Refer amounts to the total weight of the pre-penetration agent (A).

In order to read the natural and multitonal staining result particularly clearly and surprisingly at the end of the process according to the invention, the pretreatment agent (A) alone is preferably not able to be used as a separate bleaching, whitening or coloring agent. For this purpose, it is of particular advantage if the preparations ready for application (A) are free of oxidizing agents, in particular free of hydrogen peroxide and / or persulfates.

Here, "free from" means that no intentionally added compounds from the groups mentioned are contained in the agents. However, traces of these compounds can be introduced as impurity or as an impurity via other raw materials in the funds. "Free from" therefore means more specifically that the ready-to-apply agents (A) - based on their weight - less than 1 wt .-%, preferably less than 0.5 wt .-%, more preferably less than 0.25 wt. %, even more preferably contain less than 0.1 wt .-% and in particular less than 0.01 wt .-% of compounds from said groups.

Preferred processes according to the invention are characterized in that the agent (A) used in step A), based on its weight, is less than 1% by weight, preferably less than 0.5% by weight, more preferably less than 0.25 Wt .-%, even more preferably less than 0.1 wt .-% and in particular less than 0.01 wt .-% hydrogen peroxide.

Further preferred methods according to the invention are characterized in that the agent (A) used in step A), based on its weight, is less than 1% by weight, preferably less than 0.5% by weight, more preferably less than 0, 25 wt .-%, more preferably less than 0.1 wt .-% and in particular less than 0.01 wt .-% peroxo compounds.

It has been found that the effect of the pre-penetrating agent can be enhanced with regard to particularly natural and luminous multitonale colorations, if cationic surfactants are included in it. In addition, these substances cause the inventive method less damage the keratin fibers, without affecting the success of the subsequent dyeing step.

Preferred processes according to the invention are characterized in that the agent (A) additionally contains one or more cationic surfactants.

• – quartäre Imidazolinverbindung. Die im folgenden dargestellte Formel Quimi-I zeigt die Struktur dieser Verbindungen.
  
  Die Reste R stehen unabhängig voneinander jeweils für einen gesättigten oder ungesättigten, linearen oder verzweigten Kohlenwasserstoffrest mit einer Kettenlänge von 8 bis 30 Kohlenstoffatomen. Die bevorzugten Verbindungen der Formel I enthalten für R jeweils den gleichen Kohlenwasserstoffrest. Die Kettenlänge der Reste R beträgt bevorzugt 12 bis 21 Kohlenstoffatome. Besonders erfindungsgemäße Beispiele sind beispielsweise unter den INCII-Bezeichnungen Quaternium-27, Quaternium-72, Quaternium-83 und Quaternium-91 erhältlich.
• – kationische Tenside gemäß der Formel (Tkat-2), RCO-X-N⁺R¹R²R³ A^– (Tkat-2) R steht hierin für einen substituierten oder unsubstituierten, verzweigten oder geradkettigen Alkyl- oder Alkenylrest mit 11 bis 35 Kohlenstoffatomen in der Kette, X steht für -O- oder -NR⁵-, R¹ steht für eine Alkylengruppe mit 2 bis 6 C-Atomen, welche nicht substituiert oder substituiert sein kann, wobei im Falle einer Substitution die Substitution mit einer -OH- oder -NH- Gruppe bevorzugt ist, R², R³ jeweils unabhängig voneinander stehen für eine Alkyl oder Hydroxyalkylgruppe mit 1 bis zu 6 C-Atomen in der Kette, wobei die Kette geradlinig oder verzweigt sein kann. R5 steht für Wasserstoff oder einen C1 bis C6 geradkettigen oder verzweigten, Alkyl- oder Alkenylrest, welcher auch durch eine Hydroxygruppe substituiert sein kann.

As cationic surfactants it is possible according to the invention to use all cationic surfactants known and customary to the person skilled in the art. Which includes:

• - Quaternary imidazoline compound. The following formula Quimi-I shows the structure of these compounds.
  
  The radicals R independently of one another each represent a saturated or unsaturated, linear or branched hydrocarbon radical having a chain length of 8 to 30 carbon atoms. The preferred compounds of the formula I each contain the same hydrocarbon radical for R. The chain length of the radicals R is preferably 12 to 21 carbon atoms. Particularly examples according to the invention are obtainable, for example, under the INCII names Quaternium-27, Quaternium-72, Quaternium-83 and Quaternium-91.
• Cationic surfactants according to the formula (Tkat-2), RCO-XN ⁺ R ¹ R ² R ³ A ^- (Tkat-2) R herein represent a substituted or unsubstituted, branched or straight-chain alkyl or alkenyl radical having 11 to 35 carbon atoms in the chain, X is -O- or -NR ⁵ -, R ¹ is an alkylene group having 2 to 6 C atoms, which may not be substituted or substituted, wherein in the case of a substitution substitution with an -OH- or -NH- group is preferred, each of R ² , R ³ independently represents an alkyl or hydroxyalkyl group having 1 to 6 carbon atoms in the chain, which chain may be straight or branched. R5 is hydrogen or a C1 to C6 straight-chain or branched, alkyl or alkenyl radical which may also be substituted by a hydroxy group.

Within this structural class, the compounds of one of the following structures are preferably used: CH ₃ (CH ₂ ) ₂₀ CONH (CH ₂ ) ₃ - N ⁺ (CH ₃ ) ₂ -CH ₂ CH ₃ A ^- (Tkat-3) CH ₃ (CH ₂ ) ₂₀ CONH (CH ₂ ) ₃ - N ⁺ (CH ₃ ) ₂ -CH ₂ (CHOH) CH ₂ OH A ^- (Tkat-4) CH ₃ (CH ₂ ) ₂₀ COOCH ₂ CHOHCH ₂ - N ⁺ (CH ₃ ) ₃ A ^- (Tkat-5) CH ₃ (CH _{2) 20} CONH (CH _{2) 3} - N ⁺ (CH _{3) 2} -CH ₂ CH ₂ OH A ^- (Tkat-6)

• – Esterquats gemäß der Formel (Tkat1-2) verwendet werden.
  

Examples of such commercial products are Schercoquat BAS, Lexquat AMG-BEO, Akypoquat 131 or Incroquat Behenyl HE.

• - Esterquats be used according to the formula (Tkat1-2).
  

• – ein verzweigter oder unverzweigter Alkylrest mit 1 bis 4 Kohlenstoffatomen, welcher mindestens eine Hydroxylgruppe enthalten kann, oder
• – ein gesättigter oder ungesättigter, verzweigter oder unverzweigter oder ein cyclischer gesättigter oder ungesättigter Alkylrest mit 6 bis 30 Kohlenstoffatomen, welcher mindestens eine Hydroxylgruppe enthalten kann, oder
• – ein Aryl oder Alkarylrest, beispielsweise Phenyl oder Benzyl,
• – den Rest (-A-R4), mit der Maßgabe, dass höchstens 2 der Reste R1, R2 oder R3 für diesen Rest stehen können:

Here, the radicals R1, R2 and R3 are each independently and may be the same or different. The radicals R1, R2 and R3 mean:

• A branched or unbranched alkyl radical having 1 to 4 carbon atoms which may contain at least one hydroxyl group, or
• A saturated or unsaturated, branched or unbranched or cyclic saturated or unsaturated alkyl radical having from 6 to 30 carbon atoms which may contain at least one hydroxyl group, or
• An aryl or alkaryl radical, for example phenyl or benzyl,
• The radical (-A-R 4), with the proviso that at most 2 of the radicals R 1, R 2 or R 3 can be:

• 1) -(CH2)n- mit n = 1 bis 20, vorzugsweise n = 1 bis 10 und besonders bevorzugt n = 1–5, oder
• 2) -(CH2-CHR5-O)n- mit n = 1 bis 200, vorzugsweise 1 bis 100, besonders bevorzugt 1 bis 50, und besonders bevorzugt 1 bis 20 mit R5 in der Bedeutung von Wasserstoff, Methyl oder Ethyl, und

R4 steht für:

• 1) R6-O-CO-, worin R6 einen gesättigten oder ungesättigten, verzweigten oder unverzweigten oder einen cyclischen gesättigten oder ungesättigten Alkylrest mit 6 bis 30 Kohlenstoffatomen ist, welcher mindestens eine Hydroxygruppe enthalten kann, und welcher gegebenenfalls weiterhin mit 1 bis 100 Ethylenoxideinheiten und/oder 1 bis 100 Propylenoxideinheiten oxethyliert sein kann, oder
• 2) R7-CO-, worin R7 einen gesättigten oder ungesättigten, verzweigten oder unverzweigten oder einen cyclischen gesättigten oder ungesättigten Alkylrest mit 6 bis 30 Kohlenstoffatomen ist, welcher mindestens eine Hydroxygruppe enthalten kann, und welcher gegebenenfalls weiterhin mit 1 bis 100 Ethylenoxideinheiten und/oder 1 bis 100 Propylenoxideinheiten oxethyliert sein kann, und

• – Q steht für ein physiologisch verträgliches organisches oder anorganisches Anion. Solche Produkte werden beispielsweise unter den Warenzeichen Rewoquat^®, Stepantex^®, Dehyquart^® und Armocare^® vertrieben. Die Produkte Armocare^® VGH-70, ein N,N-Bis(2-Palmitoyloxyethyl)dimethylammonium-chlorid, sowie Dehyquart^® F-75, Dehyquart^® C-4046, Dehyquart^® L80, Dehyquart^® F-30, Dehyquart^® AU-35, Rewoquat^® WE18, Rewoquat^® WE38 DPG und Stepantex^® VS 90 sind Beispiele für solche Esterquats. Weitere erfindungsgemäß besonders bevorzugte Verbindungen der Formel (Tkat1-2) zählen zur Formel (Tkat1-2.1), den kationischen Betainestern.
  
  R8 entspricht in seiner Bedeutung R7.
• – Monoalkyltrimethylammoniumsalze mit einer Kettenlänge des Alkylrestes von 16 bis 24 Kohlenstoffatomen entsprechend der Formel (Tkat1-1),
  
  in denen R1, R2 und R3 für jeweils eine Methylgruppe stehen und R4 für einen gesättigten, verzweigten oder unverzweigten Alkylrest mit einer Kettenlänge von 16 bis 24 Kohlenstoffatomen. Beispiele für Verbindungen der Formel (Tkat1-1) sind Cetyltrimethylammoniumchlorid, Cetyltrimethylammoniumbromid, Cetyltrimethylammoniummethosulfat, Stearyltrimethylammoniumchlorid, Behenyltrimethylammoniumchlorid, Behenyltrimethylammoniumbromid und Behenyltrimethylammoniummethosulfat.
• – Amine und/oder kationisiertes Amine, insbesondere ein Amidoamin und/oder ein kationisiertes Amidoamin mit den folgenden Strukturformeln: R¹-NH-(CH₂)_n-NR²R³ (Tkat7) und/oder R¹-NH-(CH₂)_n-NR²R³R⁴ (Tkat8) worin R1 ein Acyl- oder Alkylrest mit 6 bis 30 C-Atomen, welche verzweigt oder unverzweigt, gesättigt oder ungesättigt sein können, und wobei der Acylrest und/oder der Alkylrest mindestens eine OH-Gruppe enthalten können, und R2, R3 und R4 jeweils unabhängig voneinander Wasserstoff oder ein Alkylrest mit 1 bis 4 C-Atomen, welcher gleich oder verschieden, gesättigt oder ungesättigt sein kann, und X^– ein Anion und n eine ganze Zahl zwischen 1 und 10 bedeuten.

The rest - (A-R4) is contained at least 1 to 3 times.
Herein A stands for:

• 1) - (CH 2) n - with n = 1 to 20, preferably n = 1 to 10 and particularly preferably n = 1-5, or
• 2) - (CH 2 -CHR 5 -O) n - with n = 1 to 200, preferably 1 to 100, particularly preferably 1 to 50, and particularly preferably 1 to 20 with R 5 in the meaning of hydrogen, methyl or ethyl, and

R4 stands for:

• 1) R 6 -O-CO-, wherein R 6 is a saturated or unsaturated, branched or unbranched or cyclic saturated or unsaturated alkyl radical having 6 to 30 carbon atoms, which may contain at least one hydroxy group, and which optionally further with 1 to 100 ethylene oxide units and or 1 to 100 propylene oxide units may be ethoxylated, or
• 2) R7-CO-, wherein R7 is a saturated or unsaturated, branched or unbranched or cyclic saturated or unsaturated alkyl radical having 6 to 30 carbon atoms, which may contain at least one hydroxy group, and which optionally further with 1 to 100 ethylene oxide units and / or 1 to 100 propylene oxide units can be ethoxylated, and

• - Q is a physiologically acceptable organic or inorganic anion. Such products are marketed under the trademarks Rewoquat ^®, Stepantex® ^{®, ®} and Dehyquart® Armocare® ^®. The products Armocare ^® VGH-70, a N, N-bis (2-palmitoyloxyethyl) dimethylammonium chloride, as well as Dehyquart ^® F-75, Dehyquart ^® C-4046, Dehyquart ^® L80, Dehyquart ^® F-30, Dehyquart ^® AU 35, Rewoquat ^® WE18, Rewoquat WE38 ^® DPG and Stepantex ^® VS 90 are examples of such esterquats. Further compounds of the formula (Tkat1-2) which are particularly preferred according to the invention belong to the formula (Tkat1-2.1), the cationic betaine esters.
  
  R8 corresponds in its meaning R7.
• Monoalkyltrimethylammonium salts having a chain length of the alkyl radical of 16 to 24 carbon atoms corresponding to the formula (Tkat1-1),
  
  in which R 1, R 2 and R 3 are each a methyl group and R 4 is a saturated, branched or unbranched alkyl radical having a chain length of 16 to 24 carbon atoms. Examples of compounds of the formula (Tkat1-1) are cetyltrimethylammonium chloride, cetyltrimethylammonium bromide, cetyltrimethylammonium methosulfate, stearyltrimethylammonium chloride, behenyltrimethylammonium chloride, behenyltrimethylammonium bromide and behenyltrimethylammonium methosulfate.
• Amines and / or cationized amines, in particular an amidoamine and / or a cationized amidoamine having the following structural formulas: R ¹ -NH- (CH ₂ ) _n -NR ² R ³ (Tkat7) and / or R ¹ -NH- (CH ₂ ) _n -NR ² R ³ R ⁴ (Tkat8) where R ^{1 is} an acyl or alkyl radical having 6 to 30 C atoms, which may be branched or unbranched, saturated or unsaturated, and wherein the acyl radical and / or the alkyl radical is at least one And R2, R3 and R4 are each independently hydrogen or an alkyl group having 1 to 4 carbon atoms, which may be the same or different, saturated or unsaturated, and X ^{- is} an anion and n is an integer between 1 and 10 mean.

Preference is given to a composition in which the amine and / or the quaternized amine according to general formulas (Tkat7) and / or (Tkat8) is an amidoamine and / or a quaternized amidoamine, in which R1 is a branched or unbranched, saturated or unsaturated acyl radical with 6 to 30 carbon atoms, which may contain at least one OH group means. Preference is given in this case to a fatty acid radical of oils and waxes, in particular of natural oils and waxes. Examples of these are lanolin, bees or candellila waxes. Also preferred are those amidoamines and / or quaternized amidoamines in which R 2, R 3 and / or R 4 in formulas (Tkat7) and / or (Tkat8) represent a radical according to the general formula CH ₂ CH ₂ OR 5, where R 5 is the meaning of alkyl radicals having 1 to 4 carbon atoms, hydroxyethyl or hydrogen. The preferred size of n in the general formulas (Tkat7) and / or (Tkat8) is an integer between 2 and 5. Further preferred are amidoamines and / or quaternized amidoamines of the general formulas (Tkat7) and / or (Tkat8), in wherein the anion X ^{- is} a halide ion or a compound of the general formula RSO ₃ ^- , wherein R has the meaning of saturated or unsaturated alkyl radicals having 1 to 4 carbon atoms. The alkyl radical having 1 to 4 carbon atoms of R 2, R 3 and R 4 and / or the alkyl radical having 1 to 4 carbon atoms of RSO ₃ ^- in the general formula (Tkat7) and / or (Tkat8) may contain at least one hydroxyl group. The alkylamidoamines can both be present as such and converted by protonation in a correspondingly acidic solution into a quaternary compound in the composition. According to the invention, the cationic alkylamidoamines are preferred.

As for inventive use amidoamines, which can optionally be quaternized, are, for example into consideration as amidoamines: Witcamine ^® 100 (Witco, INCI-name: Cocamidopropyl Dimethylamine), Incromine ^® BB (Croda, INCI name: behenamidopropyl dimethylamine), Mackine ^® 401 (McIntyre, INCI name: Isostearylamidopropyl Dimethylamine) and other Mackine types, Adogen ^® S18V (Witco, INCI name: Stearylamidopropyl Dimethylamine), and as permanent cationic aminoamines: Rewoquat ^® RTM 50 (Witco surfactants GmbH, INCI name: Ricinoleamidopropyltrimonium methosulfate), Empigen ^® CSC (Albright & Wilson, INCI name: Cocamidopropyltrimonium chloride) Swanol ^® Lanoquat OF-50 (Nikko, INCI name: quaternium-33), Rewoquat ^® UTM 50 (Witco surfactants GmbH, Undecyleneamidopropyltrimonium methosulfate).

The anion of all of the previously described cationic compounds is selected from the physiologically acceptable anions. Examples of these are the halide ions, fluoride, chloride, bromide, sulfate of the general formula RSO ₃ ^- , in which R has the meaning of saturated or unsaturated alkyl radicals having 1 to 4 carbon atoms, or anionic radicals of organic acids such as maleate, fumarate, oxalate, tartrate, Citrate, lactate or acetate, called. Preference is given to using cationic imidazolines, esterquats, cationic surfactants according to the formula (Tkat-2) and amines and / or cationized amines, in particular amidoamines and / or cationized amidoamines.

The aforementioned cationic surfactants can be used individually or in any combination with each other, wherein amounts between 0.01 to 20 wt.%, Preferably in amounts of 0.01 to 10 wt.% And most preferably in amounts of 0.1 to 7.5% by weight. The very best results are obtained with amounts of from 0.1 to 5% by weight, based in each case on the total composition of the particular agent.

The surfactants (T) are in a total amount of the surfactants in amounts of 0.05-45 wt.%, Preferably 0.1-30 wt.% And most preferably from 0.5-25 wt.%, Based on the total used according to the invention.

The pretreatment agent (A) may contain other common ingredients, these are described in detail below.

In step C) of the method according to the invention, a cosmetic agent (B) is applied to the keratinic fibers, which are still applied to the agent (A). This agent (B) contains one or more oxidation dye precursors (b1) and one or more oxidants (b2) and has a pH of 8.0 to 12.0.

Preferred processes according to the invention are characterized in that the agent (B) contains as oxidation dye precursor (b1) one or more oxidation dye precursors of the developer type and of the coupler type.

Preferred agents (B) contain at least one developer-type oxidation dye precursor. Corresponding processes according to the invention in which the agent (B) contains one or more oxidation dye precursors of the developer type as oxidation dye precursor (b1) are preferred according to the invention.

Preferred oxidation dye precursors of the developer type are p-phenylenediamine derivatives. Preferred p-phenylenediamines are selected from one or more compounds of the group p-phenylenediamine, p-toluenediamine, 2-chloro-p-phenylenediamine, 2,3-dimethyl-p-phenylenediamine, 2,6-dimethyl-p-phenylenediamine, 2 , 6-diethyl-p-phenylenediamine, 2,5-dimethyl-p-phenylenediamine, N, N-dimethyl-p-phenylenediamine, N, N-diethyl-p-phenylenediamine, N, N-dipropyl-p-phenylenediamine, 4 -Amino-3-methyl- (N, N-diethyl) aniline, N, N-bis (2-hydroxyethyl) -p-phenylenediamine, 4-N, N-bis (2-hydroxyethyl) amino-2-methylaniline , 4-N, N-bis (2-hydroxyethyl) amino-2-chloroaniline, 2- (2-hydroxyethyl) -p-phenylenediamine, 2- (1,2-dihydroxyethyl) -p-phenylenediamine, 2-fluoro -p-phenylenediamine, 2-isopropyl-p-phenylenediamine, N- (2-hydroxypropyl) -p-phenylenediamine, 2-hydroxymethyl-p-phenylenediamine, N, N-dimethyl-3-methyl-p-phenylenediamine, N-ethyl N-2-hydroxyethyl-p-phenylenediamine, N- (2,3-dihydroxypropyl) -p-phenylenediamine, N- (4'-aminophenyl) -p-phenylenediamine, N-phenyl-p-phenylenediamine, 2- (2 -Hydroxyethyloxy) -p-phenylenediamine, 2-methoxymethyl -p-phenylenediamine, 2- (2-acetylaminoethyloxy) -p-phenylenediamine, N- (2-methoxyethyl) -p-phenylenediamine, N- (4-amino-3-methylphenyl) -N- [3- (1H-imidazole -1-yl) propyl] amine, 5,8-diaminobenzo-1,4-dioxane and their physiologically acceptable salts. Particularly preferred p-phenylenediamine derivatives according to the invention are selected from at least one compound of the group p-phenylenediamine, p-toluenediamine, 2- (2-hydroxyethyl) -p-phenylenediamine, 2- (1,2-dihydroxyethyl) -p-phenylenediamine, N, N-bis- (2-hydroxyethyl) -p-phenylenediamine, N- (4-amino-3-methylphenyl) -N- [3- (1H-imidazol-1-yl) propyl] amine, 2-methoxymethyl-p- phenylenediamine and their physiologically acceptable salts. It may further be preferred according to the invention to use as developer component compounds which contain at least two aromatic nuclei which are substituted by amino and / or hydroxyl groups. In particular, preferred binuclear developer components are selected from at least one of the following compounds: N, N'-bis (2-hydroxyethyl) -N, N'-bis (4'-aminophenyl) -1,3-diaminopropan-2-ol, N, N'-bis (2-hydroxyethyl) -N, N'-bis (4'-aminophenyl) ethylenediamine, N, N'-bis (4'-aminophenyl) tetramethylenediamine, N, N'-bis- (2-hydroxyethyl) -N, N'-bis (4'-aminophenyl) tetramethylenediamine, N, N'-bis (4- (methylamino) phenyl) tetramethylenediamine, N, N'-diethyl-N, N ' bis (4'-amino-3'-methylphenyl) ethylenediamine, bis (2-hydroxy-5-aminophenyl) methane, N, N'-bis (4'-aminophenyl) -1,4-diazacycloheptane, N , N'-bis (2-hydroxy-5-aminobenzyl) -piperazine, N- (4'-aminophenyl) -p-phenylenediamine and 1,10-bis (2 ', 5'-diaminophenyl) -1,4, 7,10-tetraoxadecane and its physiologically acceptable salts. Very particularly preferred binuclear developer components are selected from N, N'-bis (2-hydroxyethyl) -N, N'-bis (4-aminophenyl) -1,3-diamino-propan-2-ol, bis (2 -hydroxy-5-aminophenyl) methane, 1,3-bis (2,5-diaminophenoxy) -propan-2-ol, N, N'-bis (4-aminophenyl) -1,4-diazacycloheptane, 1, 10-bis- (2,5-diaminophenyl) -1,4,7,10-tetraoxadecane or one of its physiologically acceptable salts. Furthermore, it may be preferred according to the invention to use as the developer component a p-aminophenol derivative or one of its physiologically tolerable salts. Particularly preferred p-aminophenols are p-aminophenol, N-methyl-p-aminophenol, 4-amino-3-methylphenol, 4-amino-3-fluorophenol, 2-hydroxymethylamino-4-aminophenol, 4-amino-3-ol hydroxymethylphenol, 4-amino-2- (2-hydroxyethoxy) phenol, 4-amino-2-methylphenol, 4-amino-2-hydroxymethylphenol, 4-amino-2-methoxymethyl-phenol, 4-amino-2-aminomethylphenol, 4-amino-2- (2-hydroxyethylaminomethyl) phenol, 4-amino-2- (1,2-dihydroxyethyl) phenol, 4-amino-2-fluorophenol, 4-amino-2-chlorophenol, 4- Amino-2,6-dichlorophenol, 4-amino-2- (diethylaminomethyl) phenol and their physiologically acceptable salts. Very particularly preferred compounds are p-aminophenol, 4-amino-3-methylphenol, 4-amino-2-aminomethylphenol, 4-amino-2- (1,2-dihydroxyethyl) phenol and 4-amino-2- (diethylaminomethyl) phenol , Furthermore, the Developer component may be selected from o-aminophenol and its derivatives, such as 2-amino-4-methylphenol, 2-amino-5-methylphenol or 2-amino-4-chlorophenol. Furthermore, the developer component may be selected from heterocyclic developer components such as pyrimidine derivatives, pyrazole derivatives, pyrazolopyrimidine and pyrazolopyrazole derivatives or their physiologically acceptable salts. Preferred pyrimidine derivatives are in particular the compounds 2,4,5,6-tetraaminopyrimidine, 4-hydroxy-2,5,6-triaminopyrimidine, 2-hydroxy-4,5,6-triaminopyrimidine, 2-dimethylamino-4,5, 6-triaminopyrimidine, 2,4-dihydroxy-5,6-diaminopyrimidine and 2,5,6-triaminopyrimidine. Preferred pyrazole derivatives are in particular the compounds which are selected from 4,5-diamino-1-methylpyrazole, 4,5-diamino-1- (2-hydroxyethyl) pyrazole, 3,4-diaminopyrazole, 4,5-diamino 1- (4'-chlorobenzyl) pyrazole, 4,5-diamino-1,3-dimethylpyrazole, 4,5-diamino-3-methyl-1-phenylpyrazole, 4,5-diamino-1-methyl-3-phenylpyrazole, 4-Amino-1,3-dimethyl-5-hydrazinopyrazole, 1-benzyl-4,5-diamino-3-methylpyrazole, 4,5-diamino-3-t-butyl-1-methylpyrazole, 4,5-diamino 1-t-butyl-3-methylpyrazole, 4,5-diamino-1- (2-hydroxyethyl) -3-methylpyrazole, 4,5-diamino-1-ethyl-3-methylpyrazole, 4,5-diamino-1 ethyl 3- (4-methoxyphenyl) pyrazole, 4,5-diamino-1-ethyl-3-hydroxymethylpyrazole, 4,5-diamino-3-hydroxymethyl-1-methylpyrazole, 4,5-diamino-3-hydroxymethyl-1 -isopropylpyrazole, 4,5-diamino-3-methyl-1-isopropylpyrazole, 4-amino-5- (2-aminoethyl) amino-1,3-dimethylpyrazole, and their physiologically tolerated salts, but in particular 4,5-diamino- 1- (2-hydroxyethyl) pyrazole. Preferred pyrazolopyrimidines are the compounds which are selected from pyrazolo [1,5-a] pyrimidine-3,7-diamine, 2,5-dimethylpyrazolo [1,5-a] pyrimidine-3,7-diamine, pyrazolo [ 1,5-a] pyrimidine-3,5-diamine, 2,7-dimethylpyrazolo [1,5-a] pyrimidine-3,5-diamine, 3-aminopyrazolo [1,5-a] pyrimidine-7 ol, 3-aminopyrazolo [1,5-a] pyrimidin-5-ol, 2- (3-aminopyrazolo [1,5-a] pyrimidin-7-ylamino) ethanol, 2- (7-aminopyrazolo [1,5- a] pyrimidin-3-ylamino) ethanol, 2 - [(3-aminopyrazolo [1,5-a] pyrimidin-7-yl) - (2-hydroxyethyl) amino] ethanol, 2 - [(7-aminopyrazolo [ 1,5-a] pyrimidin-3-yl) (2-hydroxyethyl) amino] ethanol, 5,6-dimethylpyrazolo [1,5-a] pyrimidine-3,7-diamine, 2,6-dimethylpyrazolo [1, 5-a] pyrimidine-3,7-diamine, 3-amino-7-dimethylamino-2,5-dimethylpyrazolo [1,5-a] pyrimidine and their physiologically acceptable salts and their tautomeric forms when tautomeric equilibrium is present. Preferred pyrazolopyrazole derivative is 2,3-diamino-6,7-dihydro-1H, 5H-pyrazolo [1,2-a] pyrazol-1-one.

Particularly preferred developer components are selected from at least one compound from the group p-phenylenediamine, p-toluenediamine, 2- (2-hydroxyethyl) -p-phenylenediamine, 2- (1,2-dihydroxyethyl) -p-phenylenediamine, N, N- Bis (2-hydroxyethyl) -p-phenylenediamine, 2-methoxymethyl-p-phenylenediamine, N- (4-amino-3-methylphenyl) -N- [3- (1H-imidazol-1-yl) propyl] amine, N, N'-bis (2-hydroxyethyl) -N, N'-bis (4-aminophenyl) -1,3-diamino-propan-2-ol, bis (2-hydroxy-5-aminophenyl) methane , 1,3-bis- (2,5-diaminophenoxy) propan-2-ol, N, N'-bis (4-aminophenyl) -1,4-diazacycloheptane, 1,10-bis- (2,5-) diaminophenyl) -1,4,7,10-tetraoxadecane, p-aminophenol, 4-amino-3-methylphenol, 4-amino-2-aminomethylphenol, 4-amino-2- (1,2-dihydroxyethyl) phenol, 4- Amino-2- (diethylaminomethyl) phenol, 4,5-diamino-1- (2-hydroxyethyl) pyrazole, 2,4,5,6-tetraaminopyrimidine, 4-hydroxy-2,5,6-triaminopyrimidine, 2-hydroxy 4,5,6-triaminopyrimidine, 2,3-diamino-6,7-dihydro-1H, 5H-pyrazolo [1,2-a] pyrazol-1-one and their physiologically acceptable Salt. Very particularly preferred developer components are p-toluenediamine, 2- (2-hydroxyethyl) -p-phenylenediamine, 2-methoxymethyl-p-phenylenediamine, N- (4-amino-3-methylphenyl) -N- [3- (1H-imidazole 1-yl) propyl] amine, and / or 4,5-diamino-1- (2-hydroxyethyl) pyrazole and their physiologically acceptable salts.

It has been found that certain types of developer-type oxidation dye precursors are particularly well suited for use in agent (B) and, in its applications, for particularly vivid, wash, rub, perspiration, and UV-authentic multi-tonal dyeings to lead.

Particularly preferred processes according to the invention are characterized in that the agent (B) as the oxidation dye precursor of the developer type contains one or more compounds from the group p-phenylenediamine, p-toluenediamine, 2- (2-hydroxyethyl) -p-phenylenediamine, 2- (1, 2-dihydroxyethyl) -p-phenylenediamine, N, N-bis (2-hydroxyethyl) -p-phenylenediamine, 2-methoxymethyl-p-phenylenediamine, N- (4-amino-3-methylphenyl) -N- [3 (1H-imidazol-1-yl) propyl] amine and / or their physiologically acceptable salts in a total amount of 0.1 to 3.5 wt .-%, preferably from 0.3 to 2.8 wt .-%, more preferably from 0.4 to 2.1 wt .-% and particularly preferably from 0.5 to 1.6 wt .-% - based on the total weight of the agent (B) - contains.

Further particularly preferred methods according to the invention are characterized in that the agent (B) as the oxidation dye precursor of the developer type contains one or more compounds from the group bis (2-hydroxy-5-aminophenyl) methane, 1,3-bis (2,5-bis) diaminophenoxy) propan-2-ol, N, N'-bis (4-aminophenyl) -1,4-diazacycloheptane, 1,10-bis (2,5-diaminophenyl) -1,4,7,10-tetraoxadecane , p-aminophenol, 4- and amino-3-methylphenol and / or their physiologically acceptable salts in a total amount of from 0.1 to 3.5% by weight, preferably from 0.3 to 2.8% by weight, more preferably from 0.4 to 2.1 wt .-% and particularly preferably from 0.5 to 1.6 wt .-% - based on the total weight of the agent (B) - contains.

Further particularly preferred methods according to the invention are characterized in that the agent (B) as the oxidation dye precursor of the developer type comprises one or more compounds from the group consisting of 4,5-diamino-1- (2-hydroxyethyl) pyrazole, 2,4,5,6-tetraaminopyrimidine , 4-hydroxy-2,5,6-triaminopyrimidine, 2-hydroxy-4,5,6-triaminopyrimidine, 2,3-diamino-6,7-dihydro-1H, 5H-pyrazolo [1,2-a] pyrazole -1-one and / or their physiologically acceptable salts in a total amount of 0.1 to 3.5 wt .-%, preferably from 0.3 to 2.8 wt .-%, more preferably from 0.4 to 2, 1 wt .-% and particularly preferably from 0.5 to 1.6 wt .-% - based on the total weight of the agent (B) - contains.

Further particularly preferred methods according to the invention are characterized in that the agent (B) contains as developer-type oxidation dye precursors at least one of the following combinations: p-toluenediamine / 2- (2-hydroxyethyl) -p-phenylenediamine; p-toluenediamine / 2-methoxymethyl-p-phenylenediamine; p-toluenediamine / N, N-bis (2-hydroxyethyl) -p-phenylenediamine; p-toluenediamine / 2-methoxymethyl-p-phenylenediamine; p-toluenediamine / N- (4-amino-3-methylphenyl) -N- [3- (1H-imidazol-1-yl) propyl] amine; p-toluenediamine / bis (2-hydroxy-5-aminophenyl) methane; p-toluenediamine / 4-amino-3-methylphenol; p-toluenediamine / 4,5-diamino-1- (2-hydroxyethyl) pyrazole; p-toluenediamine / 2,4,5,6-tetraaminopyrimidine; 2- (2-hydroxyethyl) -p-phenylenediamine / 2-methoxymethyl-p-phenylenediamine; 2- (2-hydroxyethyl) -p-phenylenediamine / N, N-bis (2-hydroxyethyl) -p-phenylenediamine; 2- (2-hydroxyethyl) -p-phenylenediamine / 2-methoxymethyl-p-phenylenediamine; 2- (2-hydroxyethyl) -p-phenylenediamine / N- (4-amino-3-methylphenyl) -N- [3- (1H -imidazol-1-yl) propyl] amine; 2- (2-hydroxyethyl) -p-phenylenediamine / bis (2-hydroxy-5-aminophenyl) methane; 2- (2-hydroxyethyl) -p-phenylenediamine / 4-amino-3-methyl phenol; 2- (2-hydroxyethyl) -p-phenylenediamine / 4,5-diamino-1- (2-hydroxyethyl) pyrazole; 2- (2-hydroxyethyl) -p-phenylenediamine / 2,4,5,6-tetraaminopyrimidine; 2-methoxymethyl-p-phenylenediamine / 2- (2-hydroxyethyl) -p-phenylenediamine; 2-methoxymethyl-p-phenylenediamine / 2-methoxymethyl-p-phenylenediamine; 2-methoxymethyl-p-phenylenediamine / N, N-bis (2-hydroxyethyl) -p-phenylenediamine; 2-methoxymethyl-p-phenylenediamine / 2-methoxymethyl-p-phenylenediamine; 2-methoxymethyl-p-phenylenediamine / N- (4-amino-3-methylphenyl) -N- [3- (1H -imidazol-1-yl) -propyl] amine; 2-methoxymethyl-p-phenylenediamine / bis (2-hydroxy-5-aminophenyl) methane; 2-methoxymethyl-p-phenylenediamine / 4-amino-3-methyl phenol; 2-methoxymethyl-p-phenylenediamine / 4,5-diamino-1- (2-hydroxyethyl) pyrazole; 2-methoxymethyl-p-phenylenediamine / 2,4,5,6-tetraaminopyrimidine and / or 4- and amino-3-methylphenol / 4,5-diamino-1- (2-hydroxyethyl) pyrazole and / or their physiologically acceptable salts ,

Preferably according to the invention, the agent (B) further contains one or more coupler-type oxidation dye precursors.

Coupler components do not form a significant color within the framework of the oxidative dyeing alone, but always require the presence of developer components. Therefore, it is preferred according to the invention that at least one developer component is additionally used when using at least one coupler component. Coupler components according to the invention allow at least one substitution of a chemical residue of the coupler by the oxidized form of the developer component. This forms a covalent bond between the coupler and the developer component.

Coupler components according to the invention are preferably selected as at least one compound from one of the following classes: m-aminophenol, o-aminophenol, m-diaminobenzene, o-diaminobenzene and / or derivatives thereof; Naphthalene derivatives having at least one hydroxy group; Di- or trihydroxybenzene; pyridine derivatives; pyrimidine derivatives; certain indole derivatives and indoline derivatives; Pyrazolone derivatives (for example, 1-phenyl-3-methylpyrazol-5-one); Morpholine derivatives (for example, 6-hydroxybenzomorpholine or 6-aminobenzomorpholine); Quinoxaline derivatives (for example, 6-methyl-1,2,3,4-tetrahydroquinoxaline), as well as mixtures of two or more compounds from one or more of these classes.

Preferred m-aminophenol coupler components are selected from at least one compound from the group 3-aminophenol, 5-amino-2-methylphenol, N-cyclopentyl-3-aminophenol, 3-amino-2-chloro-6-methylphenol, 2-hydroxy 4-aminophenoxyethanol, 2,6-dimethyl-3-aminophenol, 3-trifluoroacetylamino-2-chloro-6-methylphenol, 5-amino-4-chloro-2-methylphenol, 5-amino-4-methoxy-2-methylphenol , 5- (2'-hydroxyethyl) amino-2-methylphenol, 3-diethylaminophenol, N-cyclopentyl-3-aminophenol, 1,3-dihydroxy-5- (methylamino) benzene, 3-ethylamino-4-methylphenol, 2, 4-dichloro-3-aminophenol and their physiologically acceptable salts. Preferred m-diaminobenzene coupler components are selected from at least one compound from the group consisting of m-phenylenediamine, 2- (2,4-diaminophenoxy) ethanol, 1,3-bis (2,4-diaminophenoxy) propane, 1-methoxy-2- amino-4- (2'-hydroxyethylamino) benzene, 1,3-bis (2,4-diaminophenyl) propane, 2,6-bis (2'-hydroxyethylamino) -1-methylbenzene, 2 - ({3 - [( 2-hydroxyethyl) amino] -4-methoxy-5-methylphenyl} amino) ethanol, 2 - ({3 - [(2-hydroxyethyl) amino] -2-methoxy-5-methylphenyl} amino) ethanol, 2 - ({ 3 - [(2-hydroxyethyl) amino] -4,5-dimethylphenyl} amino) ethanol, 2- [3-morpholin-4-ylphenyl) amino] ethanol, 3 Amino-4- (2-methoxyethoxy) -5-methylphenylamine, 1-amino-3-bis (2'-hydroxyethyl) aminobenzene and their physiologically acceptable salts. Preferred o-diaminobenzene coupler components are selected from at least one compound from the group consisting of 3,4-diaminobenzoic acid and 2,3-diamino-1-methylbenzene and their physiologically acceptable salts. Preferred naphthalene derivatives having at least one hydroxyl group are selected from at least one compound of the group 1-naphthol, 2-methyl-1-naphthol, 2-hydroxymethyl-1-naphthol, 2-hydroxyethyl-1-naphthol, 1,3-dihydroxynaphthalene, 1, 5-dihydroxynaphthalene, 1,6-dihydroxynaphthalene, 1,7-dihydroxynaphthalene, 1,8-dihydroxynaphthalene, 2,7-dihydroxynaphthalene and 2,3-dihydroxynaphthalene. Preferred di- or trihydroxybenzenes and their derivatives are selected from at least one compound of the group resorcinol, resorcinol monomethyl ether, 2-methylresorcinol, 5-methylresorcinol, 2,5-dimethylresorcinol, 2-chlororesorcinol, 4-chlororesorcinol, pyrogallol and 1,2,4- trihydroxybenzene. Preferred pyridine derivatives are selected from at least one compound from the group consisting of 2,6-dihydroxypyridine, 2-amino-3-hydroxypyridine, 2-amino-5-chloro-3-hydroxypyridine, 3-amino-2-methylamino-6-methoxypyridine, 2, 6-Dihydroxy-3,4-dimethylpyridine, 2,6-dihydroxy-4-methylpyridine, 2,6-diaminopyridine, 2,3-diamino-6-methoxypyridine, 3,5-diamino-2,6-dimethoxypyridine, 3, 4-Diaminopyridine, 2- (2-methoxyethyl) amino-3-amino-6-methoxypyridine, 2- (4'-methoxyphenyl) amino-3-aminopyridine, and their physiologically acceptable salts. Preferred pyrimidine derivatives are selected from at least one compound of the group 4,6-diaminopyrimidine, 4-amino-2,6-dihydroxypyrimidine, 2,4-diamino-6-hydroxypyrimidine, 2,4,6-trihydroxypyrimidine, 2-amino-4- methylpyrimidine, 2-amino-4-hydroxy-6-methylpyrimidine and 4,6-dihydroxy-2-methylpyrimidine and their physiologically acceptable salts. Preferred indole derivatives are selected from at least one compound of the group 4-hydroxyindole, 6-hydroxyindole and 7-hydroxyindole and their physiologically acceptable salts. Preferred indoline derivatives are selected from at least one compound of the group 4-hydroxyindoline, 6-hydroxyindoline and 7-hydroxyindoline and their physiologically acceptable salts.

Particularly preferred coupler components according to the invention are selected from 3-aminophenol, 5-amino-2-methylphenol, 3-amino-2-chloro-6-methylphenol, 2-hydroxy-4-aminophenoxyethanol, 5-amino-4-chloro-2-methylphenol , 5- (2-hydroxyethyl) amino-2-methylphenol, 2,4-dichloro-3-aminophenol, 2-aminophenol, 3-phenylenediamine, 2- (2,4-diaminophenoxy) ethanol, 1,3-bis ( 2,4-di-aminophenoxy) propane, 1-methoxy-2-amino-4- (2-hydroxyethylamino) benzene, 1,3-bis (2,4-diaminophenyl) propane, 2,6-bis (2'-bis) hydroxyethylamino) -1-methylbenzene, 2 - ({3 - [(2-hydroxyethyl) amino] -4-methoxy-5-methylphenyl} amino) ethanol, 2 - ({3 - [(2-hydroxyethyl) amino] -2 -methoxy-5-methylphenyl} amino) ethanol, 2- ({3 - [(2-hydroxyethyl) amino] -4,5-dimethylphenyl} amino) ethanol, 2- [3-morpholin-4-ylphenyl) amino] ethanol , 3-amino-4- (2-methoxyethoxy) -5-methylphenylamine, 1-amino-3-bis (2-hydroxyethyl) aminobenzene, resorcinol, 2-methylresorcinol, 4-chlororesorcinol, 1,2,4-trihydroxybenzene, 2-amino-3-hydroxypyridine, 3-amino-2-methylamino-6-methoxypyridine, 2,6-dihydroxy 3,4-dimethylpyridine, 3,5-diamino-2,6-dimethoxypyridine, 1-phenyl-3-methylpyrazol-5-one, 1-naphthol, 1,5-dihydroxynaphthalene, 2,7-dihydroxynaphthalene, 1.7 Dihydroxynaphthalene, 1,8-dihydroxynaphthalene, 4-hydroxyindole, 6-hydroxyindole, 7-hydroxyindole, 4-hydroxyindoline, 6-hydroxyindoline, 7-hydroxyindoline or mixtures of these compounds or their physiologically acceptable salts. Very particular preference is given to resorcinol, 2-methylresorcinol, 5-amino-2-methylphenol, 3-aminophenol, 2- (2,4-diaminophenoxy) ethanol, 1,3-bis (2,4-diaminophenoxy) propane, 1-methoxy 2-amino-4- (2'-hydroxyethylamino) benzene, 2-amino-3-hydroxypyridine and 1-naphthol and one of their physiologically acceptable salts.

The coupler components are preferably used in an amount of 0.0001 to 0.5 wt .-%, preferably 0.001 to 0.2 wt .-%, each based on the agent (B).

It has been found that certain coupler-type oxidation dye precursors are particularly well-suited in certain amounts to be used in the colorant (B) and to give it particularly lively, wash-, rub-, perspiration- and UV-authentic multi-tonal dyeings to lead.

Processes preferred according to the invention are therefore characterized in that the agent (B) as coupler-type oxidation dye precursor contains one or more compounds from the group consisting of 3-aminophenol, 5-amino-2-methylphenol, 3-amino-2-chloro-6-methylphenol, 2 -Hydroxy-4-aminophenoxyethanol, 5-amino-4-chloro-2-methylphenol, 5- (2-hydroxyethyl) amino-2-methylphenol, 2,4-dichloro-3-aminophenol, 2-aminophenol and / or their physiologically acceptable salts in a total amount of from 0.1 to 3.5% by weight, preferably from 0.3 to 2.8% by weight, more preferably from 0.4 to 2.1% by weight. %, and more preferably from 0.5 to 1.6 wt .-% - based on the total weight of the agent (B) - contains.

Further preferred processes according to the invention are characterized in that the agent (B) as coupler-type oxidation dye precursor contains one or more compounds from the group consisting of 3-phenylenediamine, 2- (2,4-diaminophenoxy) ethanol, 1,3-bis (2,4- diaminophenoxy) propane, 1-methoxy-2-amino-4- (2-hydroxyethylamino) benzene, 1,3-bis (2,4-diaminophenyl) propane, 2,6-bis (2'-hydroxyethylamino) -1-methylbenzene and / or their physiologically acceptable salts in a total amount of from 0.1 to 3.5% by weight, preferably from 0.3 to 2.8% by weight, more preferably from 0.4 to 2.1% by weight. %, and more preferably from 0.5 to 1.6 wt .-% - based on the total weight of the agent (B) - contains.

Further preferred processes according to the invention are characterized in that the agent (B) as coupler-type oxidation dye precursor contains one or more compounds from the group resorcinol, 2-methylresorcinol and / or 4-chlororesorcinol in a total amount of 0.1 to 3.5% by weight. %, preferably from 0.3 to 2.8 wt .-%, more preferably from 0.4 to 2.1 wt .-% and particularly preferably from 0.5 to 1.6 wt .-% - based on the total weight of the agent (B) - contains.

Further inventively preferred methods are characterized in that the agent (B) as Oxidationsfarbstoffvorpdodukt the coupler type one or more compounds from the group 2-amino-3-hydroxypyridine, 3-amino-2-methylamino-6-methoxypyridine, 2,6-dihydroxy 3,4-dimethylpyridine, 3,5-diamino-2,6-dimethoxypyridine, 1-phenyl-3-methylpyrazol-5-one and / or their physiologically acceptable salts in a total amount of 0.1 to 3.5 wt. -%, preferably from 0.3 to 2.8 wt .-%, more preferably from 0.4 to 2.1 wt .-% and particularly preferably from 0.5 to 1.6 wt .-% - based on the Total weight of the agent (B) - contains.

Further preferred processes according to the invention are characterized in that the agent (B) as coupler-type oxidation dye precursor contains at least one of the following combinations: resorcinol / 3-aminophenol; 2-methyl / 3-aminophenol; 4-chlororesorcinol / 3-aminophenol; Resorcinol / 5-amino-2-methyl phenol; 2-methyl resorcinol / 5-amino-2-methyl phenol; 4-chlororesorcinol / 5-amino-2-methyl phenol; Resorcinol / 2-hydroxy-4-aminophenoxyethanol; 2-methyl / 2-hydroxy-4-aminophenoxyethanol; 4-chlororesorcinol / 2-hydroxy-4-aminophenoxyethanol; Resorcinol / 2-amino-3-hydroxypyridine; 2-methyl / 2-amino-3-hydroxypyridine; 4-chlororesorcinol / 2-amino-3-hydroxypyridine; Resorcinol / 3-amino-2-methylamino-6-methoxypyridine; 2-methyl / 3-amino-2-methylamino-6-methoxypyridine; 4-chlororesorcinol / 3-amino-2-methylamino-6-methoxypyridine; Resorcinol / 2,6-dihydroxy-3,4-dimethylpyridine; 2-methylresorcinol / 2,6-dihydroxy-3,4-dimethylpyridine and / or 4-chlororesorcinol / 2,6-dihydroxy-3,4-dimethylpyridine and / or their physiologically tolerated salts.

The ready-to-use agents (B) additionally contain one or more oxidants (b2). Usually, oxidative colorants are offered in the form of a two-component "kit" (multicomponent packaging unit), the first component containing the oxidation dye precursors and an alkalizing agent (eg, ammonia) and the second component containing the oxidizing agent. As oxidizing agents peroxides such as hydrogen peroxide are usually used.

The oxidation dye precursors (developers and couplers) themselves are not colored, but the formation of the actual dyes takes place only in the course of application by the contact of the oxidation dye precursors with the oxidizing agent (preferably hydrogen peroxide). In a chemical reaction, the developers used as oxidation dye precursors (such as p-phenylenediamine derivatives or p-aminophenol derivatives) are first oxidatively converted by hydrogen peroxide into a reactive intermediate, also quinone imine or quinonediimine, which then in an oxidative coupling reaction with the couplers for each Dye reacts.

All information on agent (B) above refers to the ready-to-use mixture, even if it was only obtained by mixing before the application of several preparations (B1), (B2) and so on.

As the oxidizing agent are persulfates, peroxodisulfates, chlorites, hypochlorites and in particular hydrogen peroxide or and / or one of its solid addition products of organic or inorganic compounds in question.

In order to prevent a premature, undesired reaction of the oxidation dye precursors by the oxidizing agent, oxidation dye precursors and oxidizing agents themselves are expediently prepared separately from each other and brought into contact only immediately before use.

In a further embodiment of the present invention, therefore, agents (B) are preferred, which are characterized in that they are prepared immediately before use by mixing at least two preparations, wherein the at least two preparations are provided in at least two separate prefabricated containers and wherein a Container a colorant (B1), which in one cosmetic carrier contains at least one oxidation dye precursor, and a further container contains an oxidizing agent preparation (B2) containing at least one oxidizing agent.

The oxidizing agent preparation (B2) preferably contains as the oxidizing agent hydrogen peroxide and / or one of its solid addition products of organic or inorganic compounds, such as urea, melamine and sodium borate.

Such oxidizer formulations (B2) are preferably aqueous, flowable oxidizer formulations. Preferred formulations (B2) are characterized in that the flowable oxidizing agent preparation (B2) - based on their weight - 40 to 90 wt .-%, preferably 50 to 85 wt .-%, particularly preferably 55 to 80 wt .-%, more preferably 60 to 77.5 wt .-% and in particular 65 to 75 wt .-% water.

Preferably, the amount of oxidizing agent in the ready-to-use agent (B) is 0.5 to 12% by weight, preferably 2 to 10% by weight, more preferably 3 to 6% by weight (calculated as 100% H ₂ O) ₂ ), in each case based on the ready-to-use agent (B).

In a further preferred embodiment, the agent (B) is an agent for dyeing and, if appropriate, simultaneous lightening of keratinic fibers, which is preferably 0.5 to 15% by weight, preferably 1 to 12.5% by weight, particularly preferably 1.5 to 10 wt .-% and in particular 2 to 6 wt .-% hydrogen peroxide, each based on the total weight of the ready-to-use agent (B).

According to the invention, however, the oxidation dye can also be applied to the hair together with a catalyst which activates the oxidation of the dye precursors. Such catalysts are z. For example, certain enzymes, iodides, quinones or metal ions.

It has proved to be advantageous if the oxidizing agent preparations (B2) according to the invention additionally contain at least one stabilizer or complexing agent for stabilizing the hydrogen peroxide. Particularly preferred stabilizers are in particular EDTA and EDDS, and phosphonates, in particular 1-hydroxyethane-1,1-diphosphonate (HEDP) and / or ethylenediamine tetramethylenephosphonate (EDTMP) and / or diethylenetriaminepentamethylenephosphonate (DTPMP) or their sodium salts.

In order to obtain an increased whitening and bleaching action, the agent (B) may further contain at least one peroxo salt. Suitable peroxo salts are inorganic peroxo compounds, preferably selected from the group consisting of ammonium peroxodisulfate, alkali metal peroxodisulfates, ammonium peroxomonosulfate, alkali metal peroxomonosulfates, alkali metal peroxodiphosphates and alkaline earth metal peroxides. Particularly preferred are peroxodisulfates, in particular ammonium peroxodisulfate, potassium peroxodisulfate and sodium peroxodisulfate.

The persulfates are each in an amount of 0.5 to 20 wt .-%, preferably 1 to 12.5 wt .-%, particularly preferably 2.5 to 10 wt .-% and in particular 3 to 6 wt .-%, based on the total weight of the ready-to-use agent, on average (B).

Also, the agent (B) may contain alkalizing agent, while it has been found to be particularly preferred when agent (B) has a lower pH than agent (A). Corresponding processes according to the invention in which the agent (A) has a higher pH than the agent (B) are preferred because of the higher stabilities of the dyeings.

The ready-to-use colorants (B) may further contain additional active ingredients, auxiliaries and additives in order to improve the dyeing performance and to adjust further desired properties of the agents.

The ready-to-use colorants are preferably provided as a liquid preparation, and the surfactants are additionally additionally added to a surfactant, such surfactants being referred to as surfactants or as emulsifiers, depending on the field of application:
They are preferably selected from anionic, cationic, zwitterionic, amphoteric and nonionic surfactants and emulsifiers.

Agents preferred according to the invention are characterized in that the agent additionally contains at least one anionic surfactant. Preferred anionic surfactants are fatty acids, alkyl sulfates, alkyl ether sulfates and ether carboxylic acids having 10 to 20 carbon atoms in the alkyl group and up to 16 glycol ether groups in the molecule. The anionic surfactants are used in proportions of from 0.1 to 45% by weight, preferably from 1 to 30% by weight and very particularly preferably from 1 to 15% by weight, based on the total amount of the ready-to-use agent.

Agents preferred according to the invention are characterized in that the agent additionally contains at least one zwitterionic surfactant. Preferred zwitterionic surfactants are betaines, N-alkyl-N, N-dimethylammonium glycinates, N-acylaminopropyl-N, N-dimethylammonium glycinates, and 2-alkyl-3-carboxymethyl-3-hydroxyethylimidazolines. A preferred zwitterionic surfactant is known by the INCI name Cocamidopropyl Betaine.

Agents preferred according to the invention are characterized in that the agent additionally contains at least one amphoteric surfactant. Preferred amphoteric surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids. Particularly preferred amphoteric surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and C ₁₂ -C ₁₈ acylsarcosine.

Furthermore, it has proven to be advantageous if the agents contain other, nonionic surfactants. Examples of preferred nonionic surfactants are alkylene oxide addition products of fatty alcohols and fatty acids containing 2 to 30 mol of ethylene oxide per mole of fatty alcohol or fatty acid. Preparations having excellent properties are also obtained if they contain fatty acid esters of ethoxylated glycerol as nonionic surfactants.

The nonionic, zwitterionic or amphoteric surfactants are used in proportions of from 0.1 to 45% by weight, preferably from 1 to 30% by weight and very particularly preferably from 1 to 15% by weight, based on the total amount of ready-to-use agents.

The ready-to-use colorants may contain other auxiliaries and additives. Thus, it has proved to be advantageous if the agent contains at least one thickener. With regard to these thickeners, there are no fundamental restrictions. Both organic and purely inorganic thickening agents can be used.

Suitable thickeners are anionic, synthetic polymers; cationic synthetic polymers; naturally occurring thickeners such as nonionic guar gums, scleroglucan gums or xanthan gums, gum arabic, ghatti gum, karaya gum, gum tragacanth, carrageenan gum, agar agar, locust bean gum, pectins, alginates, starch fractions and derivatives such as amylose, amylopectin and dextrins, and cellulose derivatives such as methylcellulose, carboxyalkylcelluloses and hydroxyalkylcelluloses; nonionic, synthetic polymers, such as polyvinyl alcohol or polyvinylpyrrolidinone; and inorganic thickening agents, in particular phyllosilicates such as bentonite, especially smectites, such as montmorillonite or hectorite.

• – Copolymere aus Dimethyl-diallylammoniumsalzen und Acrylsäure, z.B. Polyquaternium-22,
• – Copolymere aus Dimethyl-diallylammoniumsalzen und Methacrylsäure,
• – Copolymere aus N,N,N-Trimethyl-3-[(2-methyl-1-oxo-2-propen-1-yl)amino]-1-propanaminiumsalzen und Acrylsäure,
• – Copolymere aus N,N,N-Trimethyl-3-[(2-methyl-1-oxo-2-propen-1-yl)amino]-1-propanaminiumsalzen und Methacrylsäure,
• – Copolymere aus N,N,N-Trimethyl-2-[(2-methyl-1-oxo-2-propen-1-yl)amino]-1-ethanaminiumsalzen und Acrylsäure,
• – Copolymere aus N,N,N-Trimethyl-2-[(2-methyl-1-oxo-2-propen-1-yl)amino]-1-ethanaminiumsalzen und Methacrylsäure,
• – Copolymere aus N,N,N-Trimethyl-3-[(2-methyl-1-oxo-2-propen-1-yl)amino]-1-propanaminiumsalzen, Acrylsäure und Acrylamid, z.B. Polyquaternium-53
• – Copolymere aus N,N,N-Trimethyl-3-[(2-methyl-1-oxo-2-propen-1-yl)amino]-1-propanaminiumsalzen, Methacrylsäure und Acrylamid,
• – Copolymere aus 1-Ethenyl-3-methyl-1H-imidazoliumsalzen, 1-Ethenyl-1H-imidazol, 1-Ethenyl-2-pyrrolidinon und Methacrylsäure, z.B. Polyquaternium-86,
• – Copolymere aus 1-Ethenyl-3-methyl-1H-imidazoliumsalzen, 1-Ethenyl-1H-imidazol, 1-Ethenyl-2-pyrrolidinon und Acrylsäure.

Zwitterionic polymers may also be present in the agents according to the invention. Preferred zwitterionic polymers are selected from the group of

• Copolymers of dimethyldiallylammonium salts and acrylic acid, eg Polyquaternium-22,
• Copolymers of dimethyldiallylammonium salts and methacrylic acid,
• Copolymers of N, N, N-trimethyl-3 - [(2-methyl-1-oxo-2-propen-1-yl) amino] -1-propanaminium salts and acrylic acid,
• Copolymers of N, N, N-trimethyl-3 - [(2-methyl-1-oxo-2-propen-1-yl) amino] -1-propanaminium salts and methacrylic acid,
• Copolymers of N, N, N-trimethyl-2 - [(2-methyl-1-oxo-2-propen-1-yl) amino] -1-ethanaminium salts and acrylic acid,
• Copolymers of N, N, N-trimethyl-2 - [(2-methyl-1-oxo-2-propen-1-yl) amino] -1-ethanaminium salts and methacrylic acid,
• Copolymers of N, N, N-trimethyl-3 - [(2-methyl-1-oxo-2-propen-1-yl) amino] -1-propanaminium salts, acrylic acid and acrylamide, eg Polyquaternium-53
• Copolymers of N, N, N-trimethyl-3 - [(2-methyl-1-oxo-2-propen-1-yl) amino] -1-propanaminium salts, methacrylic acid and acrylamide,
• Copolymers of 1-ethenyl-3-methyl-1H-imidazolium salts, 1-ethenyl-1H-imidazole, 1-ethenyl-2-pyrrolidinone and methacrylic acid, eg Polyquaternium-86,
• Copolymers of 1-ethenyl-3-methyl-1H-imidazolium salts, 1-ethenyl-1H-imidazole, 1-ethenyl-2-pyrrolidinone and acrylic acid.

Mixtures of the abovementioned preferred zwitterionic polymers (c) may also be present in the compositions according to the invention.

It has also been shown that the problem according to the invention can be completely and satisfactorily resolved in particular if the agents used in the process according to the invention contain further selected formulation constituents.

Thus, it has been found that the additional presence of certain, higher-chain fatty alcohols further improves the color result of the compositions according to the invention. Therefore, it is preferred that the agents used in the process according to the invention additionally one or more fatty alcohols from the group of arachyl alcohol (Eisocan-1-ol), gadoleyl alcohol ((9Z) -eicos-9-en-1-ol), arachidonealcohol ((5Z , 8Z, 11Z, 14Z) -eicosa-5,8,11,14-tetraen-1-ol), heneicosyl alcohol (heneicosan-1-ol), behenyl alcohol (docosan-1-ol), erucyl alcohol ((13Z) docos -13-en-1-ol) and brassidyl alcohol ((13E) -docosen-1-ol).

Particularly suitable agents contain one or more higher-chain alcohols of the abovementioned group in a total amount of from 1.0 to 10.0% by weight, preferably from 1.4 to 8.0% by weight, more preferably from 1.8 to 6 , 0 wt .-% and particularly preferably from 2.0 to 4.0 wt .-% - based on the total weight of the ready-to-use agent.

In a further preferred embodiment, an agent used in the process according to the invention is therefore characterized in that it additionally contains one or more fatty alcohols from the group of arachyl alcohol (eicosan-1-ol), gadoleyl alcohol ((9Z) -eicos-9-en-1-ol ), Arachidonic alcohol ((5Z, 8Z, 11Z, 14Z) -eicosa-5,8,11,14-tetraen-1-ol), heneicosyl alcohol (heneicosan-1-ol), behenyl (docosan-1-ol), erucyl alcohol ((13Z) -docos-13-en-1-ol) and brassidyl alcohol ((13E) -docosen-1-ol) in a total amount of from 0.1 to 10.0% by weight, preferably from 1.4 to 8.0 wt .-%, more preferably from 1.8 to 6.0 wt .-% and particularly preferably from 2.0 to 4.0 wt .-% - based on the total weight of the ready-to-use agent - contains.

It has been shown that pretreatment at slightly elevated temperatures makes the multi-sound effects even more vivid. Processes preferred according to the invention are characterized in that the agent (A) in step B) is allowed to act at a temperature of at least 40 ° C.

Claims (15)

A process for the oxidative dyeing of keratinic fibers, comprising the steps A) application of a cosmetic agent (A) to the fibers, B) exposure of the agent (A) for a period of 30 seconds to 30 minutes, C) application of a cosmetic agent (B ) on the keratinic fibers still applied to the agent (A), D) exposure of both agents (A) and (B) for a period of 5 to 45 minutes, E) rinsing out of the agents (A) and (B) characterized in that - the agent (A) (a1) contains no oxidation dye precursors, (a2) has a pH of 8.0 to 14.0, - the agent (B) contains (b1) one or more oxidation dye precursors, (b2) contains one or more oxidizing agents and (b3) has a pH of 8.0 to 12.0. Process according to Claim 1, characterized in that the agent (A) comprises one or more alkalizing agents selected from the group consisting of sodium hydroxide, potassium hydroxide, ammonia, monoethanolamine and 2-amino-2-methyl-1-propanol in a total amount of from 0.3 to 4, 5 wt .-%, preferably 0.5 to 3.5 wt .-%, more preferably from 0.7 to 2.5 wt .-% and particularly preferably from 0.9 to 1.5 wt .-% - related on the total weight of the agent (A) - contains. Process according to any one of Claims 1 to 2, characterized in that the agent (A) contains one or more combinations of the following alkalizing agents: sodium hydroxide / potassium hydroxide; Sodium hydroxide / monoethanolamine; Potassium hydroxide / monoethanolamine; Sodium hydroxide / ammonia; Potassium hydroxide / ammonia; Monoethanolamine / 2-amino-2-methyl-1-propanol; Sodium hydroxide / 2-amino-2-methyl-1-propanol and / or potassium hydroxide / 2-amino-2-methyl-1-propanol. Method according to one of claims 1 to 3, characterized in that the agent (A), a pH (a2) of 8.5 to 11.5, preferably from 8.8 to 11.0, more preferably from 9, 0 to 10.8, and more preferably from 9.2 to 10.5. Method according to one of claims 1 to 4, characterized in that the agent (A) in step B) for a period of 30 seconds to 15 minutes, preferably from 30 seconds to 10 minutes and more preferably from 30 seconds to 5 minutes act becomes. Method according to one of claims 1 to 5, characterized in that the agent (A), additionally contains at least one thickener and / or at least one gelling agent. Method according to one of claims 1 to 6, characterized in that the agent (A) additionally contains one or more cationic surfactants. Method according to one of claims 1 to 7, characterized in that the means (B) as oxidation dye precursors (b1) contains at least one oxidation dye precursor of the developer type and at least one coupler type oxidation dye precursor. Method according to one of claims 1 to 9, characterized in that the means (B) as oxidation dye precursor (b1) one or more oxidation dye precursors of the coupler type from the group 3-aminophenol, 5-amino-2-methylphenol, 3-amino-2 chloro-6-methylphenol, 2-hydroxy-4-aminophenoxyethanol, 5-amino-4-chloro-2-methylphenol, 5- (2-hydroxyethyl) amino-2-methylphenol, 2,4-dichloro-3-aminophenol, 2-aminophenol and / or its physiologically acceptable salts in a total amount of 0.1 to 3.5 wt .-%, preferably from 0.3 to 2.8 wt .-%, more preferably from 0.4 to 2.1 Wt .-% and particularly preferably from 0.5 to 1.6 wt .-% - based on the total weight of the agent (B) - contains. Method according to one of claims 1 to 9, characterized in that the means (B) as oxidation dye precursor (b1) one or more oxidation dye precursors of the coupler type from the group 3-phenylenediamine, 2- (2,4-diaminophenoxy) ethanol, 1.3 Bis (2,4-diaminophenoxy) propane, 1-methoxy-2-amino-4- (2-hydroxyethylamino) benzene, 1,3-bis (2,4-diaminophenyl) propane, 2,6-bis (2 ' -hydroxyethylamino) -1-methylbenzene and / or their physiologically acceptable salts in a total amount of from 0.1 to 3.5% by weight, preferably from 0.3 to 2.8% by weight, more preferably from 0.4 to 2.1 wt .-% and particularly preferably from 0.5 to 1.6 wt .-% - based on the total weight of the agent (B) - contains. Method according to one of claims 1 to 10, characterized in that the means (B) as oxidation dye precursor (b1) one or more oxidation dye precursors of the coupler type from the group resorcinol, 2-methylresorcinol and / or 4-chlororesorcinol in a total amount of 0.1 to 3.5 wt .-%, preferably from 0.3 to 2.8 wt .-%, more preferably from 0.4 to 2.1 wt .-% and particularly preferably from 0.5 to 1.6 wt. -% - based on the total weight of the agent (B) - contains. Method according to one of claims 1 to 11, characterized in that the means (B) as oxidation dye precursor (b1) one or more oxidation dye precursors of the coupler type from the group 2-amino-3-hydroxypyridine, 3-amino-2-methylamino-6 methoxypyridine, 2,6-dihydroxy-3,4-dimethylpyridine, 3,5-diamino-2,6-dimethoxypyridine, 1-phenyl-3-methylpyrazol-5-one and / or their physiologically acceptable salts in a total amount of 0.1 to 3.5 wt .-%, preferably from 0.3 to 2.8 wt .-%, more preferably from 0.4 to 2.1 wt .-% and particularly preferably from 0.5 to 1.6 wt. % - based on the total weight of the agent (B) - contains. Method according to one of claims 1 to 12, characterized in that the agents (A) and (B) in step D) for a period of 5 to 30 minutes, preferably from 5 to 20 minutes, particularly preferably from 5 to 15 minutes act to be left. Method according to one of claims 1 to 13, characterized in that the agent (A) has a higher pH than the agent (B). Method according to one of claims 1 to 14, characterized in that the agent (A) in step B) is allowed to act at a temperature of at least 40 ° C.